How Psychedelics Dissolve The Boundary Between Self And Other

In 2012, Robin Carhart-Harris and colleagues at Imperial College London published the first modern fMRI study of psilocybin in healthy volunteers. What they found was counterintuitive: rather than showing increased brain activity — which most people assume from a "mind-expanding" drug — psilocybin produced significant decreases in blood flow and neural oscillation in specific regions. The most affected was the default mode network.

The default mode network (DMN) is a set of brain regions — primarily the medial prefrontal cortex, posterior cingulate cortex, and inferior parietal lobule — that are most active during self-referential thought: rumination, planning, narrative self-construction, mental time travel. It is, roughly speaking, the neural substrate of the ego. When you are worrying about something you said last week, or imagining how you will handle tomorrow's meeting, or telling yourself the story of who you are and why people treat you a certain way — the DMN is doing most of that work.

Psilocybin suppresses DMN activity. And when DMN activity drops below a certain threshold, people begin to report the dissolution of the self-other boundary. The experience is not metaphorical. Subjects describe it as ontologically real — not "I felt connected to things" but "there was no 'I' to feel separate from anything."

The brain does not go blank. What happens is more interesting: cross-network connectivity increases dramatically. Regions that rarely communicate directly — visual cortex with frontal regions, default mode with the limbic system, salience network with areas usually kept separate — begin to synchronize. The brain's normal hierarchical organization temporarily flattens. Carhart-Harris has described this as a shift from "high-entropy" to "low-entropy" processing, and then further — at the peak of the experience — into a state of maximum entropy where the brain's usual categorical structures dissolve entirely.

This maps precisely onto what phenomenologists call "mystical experiences." William James, writing in 1902 in The Varieties of Religious Experience, identified four core features of mystical states: noetic quality (the sense that something real and important is being learned), ineffability, transiency, and passivity. Carhart-Harris and colleagues developed the Mystical Experience Questionnaire to measure these states, and consistently find that psilocybin produces them at rates far exceeding placebo — and that the depth of the mystical experience predicts therapeutic outcomes better than any other variable.

This is the finding that should stop everyone cold: the more completely a person loses their sense of separate self during the session, the better they tend to do afterward on measures of depression, anxiety, addiction, and well-being. The ego dissolution is not a side effect. It appears to be the mechanism.

The phenomenology is worth dwelling on, because the experience has a consistent structure that crosses cultures, substances, and individuals.

The early stages are often perceptual: colors intensify, patterns emerge, time distorts. This phase is well-described and usually what people focus on when they talk about psychedelics culturally.

But the deeper phase — which typically emerges 2-4 hours into a high-dose session — is categorically different. Subjects describe:

- The dissolution of subject-object distinction. The experience of perceiving and the thing perceived merge. There is no longer a "me" looking at a thing over "there." - A sense of unconditional love and connection. Not sentimental. Not directed at any particular person. More like a recognition that love is the basic texture of reality, not something that has to be earned or generated. - The recognition of the self as construct. Not as an intellectual insight but as a direct perception. The narrator goes quiet, and what remains does not feel diminished — it feels vaster. Many people describe this as the most important experience of their lives, and also as something they cannot adequately put into words. - A reversal of the usual felt relationship between self and universe. Instead of experiencing oneself as a small thing inside a large universe, the experience is often of being the container, or of containing everything, or of self and universe being the same process viewed from different angles.

These descriptions are structurally identical to accounts from Christian contemplative mystics (Meister Eckhart's "God and I are one"), Sufi masters (Ibn Arabi's concept of wahdat al-wujud, the unity of being), Advaita Vedanta (the realization that atman is Brahman, individual self is universal self), and Zen Buddhism (the experience of satori or kensho, often described as the direct perception that the separation of self and Buddha-nature was always an illusion).

The convergence across traditions that have no historical contact with each other is significant. It is not evidence of a single metaphysical truth — we should stay humble about that — but it is strong evidence that the human nervous system has a consistent capacity to experience reality in a mode that registers unity rather than separation. And that mode is not pathological. It is associated with increased mental health, increased prosocial behavior, increased ecological concern, and increased life satisfaction.

The current renaissance in psychedelic research has produced results that, had they come from any other intervention, would be front-page news every week.

Johns Hopkins (2020): A randomized controlled trial published in JAMA Psychiatry found that two psilocybin sessions produced rapid, substantial, and sustained reductions in major depressive disorder in 71% of participants. Four weeks after treatment, 54% were in remission. Compare this to antidepressants, which produce remission in roughly 30-40% of patients after months of daily medication — and carry significant side effects.

Imperial College London (2021): A head-to-head trial comparing psilocybin therapy to escitalopram (a leading SSRI) for depression found that psilocybin produced faster and more robust improvements in well-being and connectedness, with fewer side effects, across a six-week trial.

NYU (2016): A single high-dose psilocybin session produced immediate, substantial, and sustained reductions in cancer-related anxiety and depression. At six-month follow-up, 80% of participants showed clinically significant reductions in depression, and 60-80% showed significant reductions in anxiety. Most attributed the experience to lasting improvements in their relationship with mortality, other people, and meaning.

University of Alabama at Birmingham (2017): Psilocybin-assisted therapy produced significant reductions in alcohol use disorder, with abstinence rates approximately double those of conventional treatment at 36-week follow-up.

The consistency of the findings across different institutions, different patient populations, and different conditions suggests a mechanism rather than a fluke. And the mechanism, consistently implicated, is the mystical experience — the ego dissolution, the felt sense of connection, the dissolution of the boundary between self and world.

The popular narrative about psychedelics focuses on the compound itself. The research makes clear that the compound is only one variable, and possibly not the most important one.

Set refers to mindset — the beliefs, expectations, fears, intentions, and psychological state the person brings to the experience. Psilocybin amplifies whatever is present. Someone entering with unresolved trauma and no preparation may have a terrifying experience. Someone entering with genuine intention and openness is more likely to access the mystical states associated with therapeutic benefit.

Setting refers to the physical and relational environment — whether the person is in a safe, comfortable space, whether there is a trained guide present, whether the music and lighting and physical comfort are optimal. Clinical settings that take setting seriously show dramatically better outcomes than experiments conducted in sterile hospital rooms.

Integration is arguably the most underdiscussed variable. The experience alone does not produce change. What the person does with it — the reflection, the conversations, the behavioral changes, the sustained practice — determines whether the insight becomes transformation or just memory. Many people describe profound experiences that fade within months because they had no integration support, no framework for incorporating what they saw, no community or practice to anchor the new perspective.

This is why the "chemical shortcut" framing misses something important. Psychedelics can provide a rapid, vivid, and unambiguous glimpse of ego dissolution and unity — an experience that might take years of meditation to approximate. But the work of actually reorganizing your life around that glimpse is still work. It still requires time, honesty, and willingness to change.

The research is exciting. The risks are real and should not be minimized.

Psilocybin can produce severe psychological distress in people with personal or family history of psychosis or bipolar disorder. This is not a theoretical concern — the research protocols specifically exclude these populations, and recreational use outside clinical settings has produced lasting adverse effects in vulnerable individuals.

The current research is conducted under carefully controlled conditions with trained guides, extensive preparation, and follow-up integration support. The results cannot simply be extrapolated to unsupported recreational use. A remarkable experience in a bad setting with no integration is not the same thing as clinical psychedelic therapy.

There is also a risk of premature certainty. The research is promising and the effect sizes are large, but the trials are still relatively small and short-term. Long-term safety data is limited. The mechanisms are not fully understood. This is a field that deserves serious scientific attention, not hype.

Beyond the therapeutic applications, the existence and reproducibility of ego dissolution raises a question that belongs at the center of any serious account of human unity.

Why does this mechanism exist?

The default mode network, and the ego-like structure it generates, evolved for a reason. It is functionally useful — it helps you navigate social hierarchies, maintain reputation, plan for the future, and coordinate complex behavior across time. The sense of being a separate self is not a bug. It is a feature. In many contexts, it is a necessary feature.

But the DMN can also suppress it. The brain has the capacity to step outside of ego-constructed reality and perceive from a mode in which separation is not the primary organizing principle. This capacity is not vestigial — it appears to be maintained across human evolution, present in every culture's contemplative traditions, capable of being accessed through multiple pathways (meditation, breathwork, sensory deprivation, near-death experiences, extreme physical exertion, certain kinds of grief).

This is not random. When a biological structure is maintained across millions of years of evolution and expressed consistently across thousands of years of human culture, the scientific default assumption is that it serves a function.

The ego-dissolution capacity may be what allows humans to periodically step outside their individual survival calculus and perceive themselves as members of something larger — family, community, species, ecosystem. It may be the biological basis for what every wisdom tradition means by words like "sacred" or "holy" — the felt recognition of something larger than the individual self, to which the individual self belongs.

If that is right — and the convergent evidence from neuroscience, phenomenology, and clinical research suggests it might be — then the experience produced by psilocybin and similar compounds is not an aberration. It is a feature of human consciousness that most people in industrialized societies have been trained out of accessing. And the consequence of that inaccessibility — billions of people living their entire lives in the mode of maximum ego-separation, unable to genuinely feel their connection to each other or to the natural world — may be legible in the state of the world.

Not as an excuse. Not as a prescription for everyone to take psychedelics. But as an invitation to take seriously the idea that the wall between self and other is not permanent, not natural, not inevitable — and that on the other side of that wall is a quality of perception and relationship and moral concern that the current global moment desperately needs.

For those with no access to or interest in psychedelic substances:

The same neural pathways can be accessed through other means. The evidence is increasingly clear that deep meditation — particularly open monitoring meditation and non-dual awareness practices — produces overlapping effects on the default mode network. A 2018 study found that experienced meditators show reduced DMN activity at rest similar to what psilocybin produces, and that the depth of no-self experiences in meditation correlates with similar personality changes (increased openness, decreased neuroticism) as psilocybin-occasioned experiences.

Practices worth exploring: - Open awareness meditation: Rather than focusing on a single object (breath, mantra), practice simply being aware of awareness itself, without directing attention. 20 minutes daily for 3 months shows measurable DMN changes. - Awe practices: Research by Dacher Keltner at UC Berkeley shows that experiences of awe — in nature, music, art, or encounters with scale — reliably reduce self-salience and increase prosocial behavior through overlapping mechanisms. - Holotropic breathwork: A technique developed by Stanislav Grof that uses controlled hyperventilation and evocative music to produce non-ordinary states of consciousness. Less well-researched but shows overlapping phenomenology with psychedelic states.

For those exploring psychedelic research:

The most important thing is preparation and integration, not the experience itself. If legal research programs exist in your jurisdiction (currently operating in Oregon and Colorado in the US, and in various clinical trial settings globally), prioritize programs with trained guides and integration support. The experience without the container is meaningfully less effective and potentially riskier.

Journaling immediately after any significant altered state experience — capturing the images, the insights, the felt sense before the language of everyday consciousness reasserts itself — is one of the most consistent markers of better long-term integration outcomes in the clinical literature.

For everyone:

The central question this topic raises is not "should I use psychedelics?" It is: what parts of my ordinary consciousness are actually constructing the experience of separation I take for granted? Where am I building and maintaining walls that are not facts but habits? And what would it mean to live, even partially, from the recognition that those walls are thinner than I think?

That question can be asked — and productively explored — without any substance whatsoever.

---

Carhart-Harris, R., et al. (2012). Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. PNAS. Davis, A., et al. (2020). Effects of psilocybin-assisted therapy on major depressive disorder. JAMA Psychiatry. Carhart-Harris, R., et al. (2021). Trial of psilocybin versus escitalopram for depression. NEJM. Griffiths, R., et al. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer. Journal of Psychopharmacology. James, W. (1902). The Varieties of Religious Experience. Longmans Green. Keltner, D., & Haidt, J. (2003). Approaching awe, a moral, spiritual, and aesthetic emotion. Cognition and Emotion.